142 related articles for article (PubMed ID: 16401837)
1. Vascular endothelial growth factor and POEMS.
Dyck PJ; Engelstad J; Dispenzieri A
Neurology; 2006 Jan; 66(1):10-2. PubMed ID: 16401837
[No Abstract] [Full Text] [Related]
2. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Kikkawa Y; Nishimura M; Nakaseko C; Cho RK; Hattori T
Neurology; 2006 Jan; 66(1):105-7. PubMed ID: 16401856
[TBL] [Abstract][Full Text] [Related]
3. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation.
Goto H; Nishio M; Kumano K; Fujimoto K; Yamaguchi K; Koike T
Bone Marrow Transplant; 2008 Nov; 42(9):627-9. PubMed ID: 18660839
[No Abstract] [Full Text] [Related]
5. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
[TBL] [Abstract][Full Text] [Related]
6. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation].
Takai K; Niikuni K; Kurasaki T
Rinsho Ketsueki; 2004 Oct; 45(10):1111-4. PubMed ID: 15553046
[TBL] [Abstract][Full Text] [Related]
8. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
9. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
10. VEGF and osteosclerosis in POEMS syndrome.
Gütgemann I; Stevens K; Loftus D; Schmidt-Wolf IG; George TI
Ann Hematol; 2008 Mar; 87(3):243-5. PubMed ID: 18172647
[No Abstract] [Full Text] [Related]
11. Coexistence of primary AL amyloidosis and POEMS syndrome: efficacy of melphalan-dexamethasone and role of biochemical markers in monitoring the diseases course.
Adami F; Briani C; Binotto G; Altinier S; Tarantini G; Semenzato G
Am J Hematol; 2010 Feb; 85(2):131-2. PubMed ID: 20029992
[No Abstract] [Full Text] [Related]
12. Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.
Bianco M; Terenghi F; Gallia F; Nozza A; Scarale A; Fayoumi MZ; Giannotta C; Nobile-Orazio E
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):367-368. PubMed ID: 29945880
[No Abstract] [Full Text] [Related]
13. Allografting or autografting for myeloma.
Rajkumar SV; Kyle RA
N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600891
[No Abstract] [Full Text] [Related]
14. POEMS syndrome.
Dispenzieri A
Blood Rev; 2007 Nov; 21(6):285-99. PubMed ID: 17850941
[TBL] [Abstract][Full Text] [Related]
15. [Autologous peripheral blood stem cell transplantation for POEMS syndrome].
Liao LS; Zheng ZH; Qu S; Wei TN; Xie Y; Lin Y; Chen BY; Chen WM
Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):209-212. PubMed ID: 30803180
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?
Tomkins O; Keddie S; Lunn MP; D'Sa S
Br J Haematol; 2019 Sep; 186(6):e178-e181. PubMed ID: 31215033
[No Abstract] [Full Text] [Related]
17. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
Lazarus HM; Phillips GL; Herzig RH; Hurd DD; Wolff SN; Herzig GP
J Clin Oncol; 2008 May; 26(14):2240-3. PubMed ID: 18467711
[No Abstract] [Full Text] [Related]
18. A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation.
Créange A; Chater A; Brouet JC; Jaccard A; Rahmouni A; Lefaucheur JP; Santin A
Nat Clin Pract Neurol; 2008 Dec; 4(12):686-91. PubMed ID: 19043425
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
[TBL] [Abstract][Full Text] [Related]
20. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
Ganti AK; Pipinos I; Culcea E; Armitage JO; Tarantolo S
Am J Hematol; 2005 Jul; 79(3):206-10. PubMed ID: 15981232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
